Millrace Asset Group’s NeoGenomics NEO Stock Holding History

Millrace Asset Group’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-24,645	Closed	-$399K	–	80
2023 Q4	$399K	Buy	+24,645	New	+$403K	0.39%	65
2018 Q1	–	Sell	-47,568	Closed	-$421K	–	69
2017 Q4	$421K	Sell	47,568 -68,854	-59%	-$635K	0.4%	60
2017 Q3	$1.3M	Sell	116,422 -58,578	-33%	-$570K	1.22%	42
2017 Q2	$1.57M	Buy	175,000 +120,000	+218%	+$952K	1.49%	35
2017 Q1	$434K	Sell	55,000 -125,738	-70%	-$1.02M	0.44%	55
2016 Q4	$1.55M	Buy	+180,738	New	+$1.55M	1.69%	27

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millrace Asset Group's NEO Position: Q1 2024 in Review

Millrace Asset Group sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 24,645 shares — an estimated $399K sold.

Millrace Asset Group first reported a position in NEO in Q4 2016 and held it in 6 quarters. The position peaked at $1.57M in Q2 2017. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

Millrace Asset Group reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
Millrace Asset Group sold 24,645 NeoGenomics shares in Q1 2024, an estimated $399K.
Millrace Asset Group first reported a position in NeoGenomics in Q4 2016 and held it in 6 quarters.
Millrace Asset Group's NeoGenomics position peaked at $1.57M in Q2 2017.
263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Millrace Asset Group's 13F filing for Q1 2024, filed 13 May 2024.